Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

COVID-19 Research

For Media

Call: 858-249-0456
Page: 619-290-2688
Email:

For Patients:

Call UC San Diego Health main patient line: 858-657-7000
Visit: health.ucsd.edu/COVID

In early February 2020, UC San Diego Health began receiving patients with a novel coronavirus infection who had been transported in quarantine by the federal government from Wuhan, China to the nearby Marine Corps Air Station Miramar. 

The virus and the disease didn’t even have names yet, but within a month, UC San Diego scientists were already doing what they do best—collaborating to learn more about the virus called SARS-CoV-2 and quickly translating their findings to help prevent and treat what we now call COVID-19. 

In many cases, labs pivoted the focus of their research seemingly overnight, coordinating efforts remotely after California’s stay-at-home order went into effect. The articles below describe some of their efforts.

Research by Topic

How COVID-19 affects body and mind

Testing and screening

Therapies

Vaccines

Other effects of the pandemic

Publications coming soon

 

Podcast

 

Photo Gallery


  • Remdesivir Getty

    UC San Diego researchers are conducting a clinical trial to determine if remdesivir, an investigational antiviral drug, may be a safe and effective agent against the novel coronavirus that causes COVID-19.

  • rana25hc

    UC San Diego researchers have found that SARS-CoV-2 infection (green, left) is inhibited when cells are treated with a natural product that removes cell membrane cholesterol (right).

  • sars-cov-2-SEM4-niaid-rml

    The novel coronavirus SARS-CoV-2 as viewed by scanning electron microscopy. Credit: NIAID/NIH

  • sars-cov-2-TEM5-niaid-rml

    The novel coronavirus SARS-CoV-2 as viewed by transmission electron microscopy. Credit: NIAID/NIH

  • sars-cov-2-SEM6-niaid-rml

    The novel coronavirus SARS-CoV-2 as viewed by scanning electron microscopy. Credit: NIAID/NIH

  • sars-cov-2-TEM7-niaid-rml

    The novel coronavirus SARS-CoV-2 as viewed by transmission electron microscopy. Credit: NIAID/NIH

  • Tocilizumab Actemra

    Clinical trials at UC San Diego Health and elsewhere will assess whether tocilizumab can treat COVID-19 pneumonia.

  • David at Pride

    David Pride, MD, PhD, director of the Clinical Molecular Microbiology Laboratory, and team developed UC San Diego Health’s robust COVID-19 testing capabilities. Credit: UC San Diego Health.